JP6615130B2 - 安定化デスモプレシン - Google Patents

安定化デスモプレシン Download PDF

Info

Publication number
JP6615130B2
JP6615130B2 JP2016573603A JP2016573603A JP6615130B2 JP 6615130 B2 JP6615130 B2 JP 6615130B2 JP 2016573603 A JP2016573603 A JP 2016573603A JP 2016573603 A JP2016573603 A JP 2016573603A JP 6615130 B2 JP6615130 B2 JP 6615130B2
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
desmopressin
gum
pharmaceutically acceptable
acceptable salt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2016573603A
Other languages
English (en)
Japanese (ja)
Other versions
JP2017523955A5 (enExample
JP2017523955A (ja
Inventor
サン イ,ボン
パク,ス−ジュン
ハン,ジヨン
キル,ミョンチョル
キム,ミンソプ
Original Assignee
フェリング ベスローテン フェンノートシャップ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=53510836&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=JP6615130(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by フェリング ベスローテン フェンノートシャップ filed Critical フェリング ベスローテン フェンノートシャップ
Publication of JP2017523955A publication Critical patent/JP2017523955A/ja
Publication of JP2017523955A5 publication Critical patent/JP2017523955A5/ja
Application granted granted Critical
Publication of JP6615130B2 publication Critical patent/JP6615130B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08Peptides having 5 to 11 amino acids
    • A61K38/095Oxytocins; Vasopressins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/70Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007Drug-containing films, membranes or sheets
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12Antidiuretics, e.g. drugs for diabetes insipidus

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Inorganic Chemistry (AREA)
  • Physiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
JP2016573603A 2014-06-16 2015-06-15 安定化デスモプレシン Active JP6615130B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR1020140073067 2014-06-16
KR1020140073067A KR20150144209A (ko) 2014-06-16 2014-06-16 안정화된 데스모프레신 또는 이의 약학적으로 허용가능한 염을 함유 약학 조성물
PCT/EP2015/063347 WO2015193246A1 (en) 2014-06-16 2015-06-15 Stabilized desmopressin

Publications (3)

Publication Number Publication Date
JP2017523955A JP2017523955A (ja) 2017-08-24
JP2017523955A5 JP2017523955A5 (enExample) 2018-07-19
JP6615130B2 true JP6615130B2 (ja) 2019-12-04

Family

ID=53510836

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016573603A Active JP6615130B2 (ja) 2014-06-16 2015-06-15 安定化デスモプレシン

Country Status (33)

Country Link
US (1) US20170128521A1 (enExample)
EP (1) EP3154516B1 (enExample)
JP (1) JP6615130B2 (enExample)
KR (2) KR20150144209A (enExample)
CN (1) CN106456706B (enExample)
AR (1) AR100850A1 (enExample)
AU (1) AU2015276247C1 (enExample)
CA (1) CA2951768C (enExample)
CL (1) CL2016003219A1 (enExample)
CO (1) CO2017000354A2 (enExample)
DK (1) DK3154516T3 (enExample)
EA (1) EA032834B1 (enExample)
ES (1) ES2751600T3 (enExample)
HR (1) HRP20191746T1 (enExample)
HU (1) HUE045395T2 (enExample)
IL (1) IL249538A0 (enExample)
JO (1) JO3500B1 (enExample)
LT (1) LT3154516T (enExample)
MX (1) MX374540B (enExample)
MY (1) MY182781A (enExample)
NZ (1) NZ727388A (enExample)
PH (1) PH12016502527A1 (enExample)
PL (1) PL3154516T3 (enExample)
PT (1) PT3154516T (enExample)
RS (1) RS59449B1 (enExample)
SA (1) SA516380492B1 (enExample)
SG (2) SG11201609374YA (enExample)
SI (1) SI3154516T1 (enExample)
TN (1) TN2016000561A1 (enExample)
TW (1) TWI670070B (enExample)
UA (1) UA119776C2 (enExample)
WO (1) WO2015193246A1 (enExample)
ZA (1) ZA201608020B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114432424B (zh) * 2021-12-27 2023-06-27 南通联亚药业股份有限公司 一种稳定的铝塑包装去氨加压素片剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE60941B1 (en) * 1986-07-10 1994-09-07 Elan Transdermal Ltd Transdermal drug delivery device
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
AU2003233118B8 (en) * 2002-05-07 2009-07-30 Ferring Bv Desmopressin in an orodispersible dosage form
WO2007083323A2 (en) * 2006-01-23 2007-07-26 Panacea Biotec Limited. Modified release oral dosage form comprising desmopressin
CN100463674C (zh) * 2006-12-22 2009-02-25 江苏奥赛康药业有限公司 一种氯雷他定口腔速溶膜及其制备方法
TW201422254A (zh) * 2012-11-21 2014-06-16 Ferring Bv 用於速釋及延釋的組成物
US20150306170A1 (en) * 2012-11-21 2015-10-29 Ferring B.V. Composition for immediate and extended release

Also Published As

Publication number Publication date
MY182781A (en) 2021-02-05
TW201605464A (zh) 2016-02-16
ES2751600T3 (es) 2020-04-01
BR112016029417A8 (pt) 2021-06-29
DK3154516T3 (da) 2019-09-23
CA2951768C (en) 2022-08-30
AU2015276247B2 (en) 2019-09-12
AR100850A1 (es) 2016-11-02
AU2015276247A1 (en) 2017-02-02
IL249538A0 (en) 2017-02-28
US20170128521A1 (en) 2017-05-11
HUE045395T2 (hu) 2019-12-30
EP3154516B1 (en) 2019-09-04
UA119776C2 (uk) 2019-08-12
CA2951768A1 (en) 2015-12-23
SI3154516T1 (sl) 2019-11-29
CN106456706A (zh) 2017-02-22
EA032834B1 (ru) 2019-07-31
LT3154516T (lt) 2019-10-25
PL3154516T3 (pl) 2020-08-10
RS59449B1 (sr) 2019-11-29
CN106456706B (zh) 2020-07-14
PH12016502527B1 (en) 2017-04-10
KR20170020450A (ko) 2017-02-22
BR112016029417A2 (pt) 2017-08-22
SA516380492B1 (ar) 2021-02-03
TWI670070B (zh) 2019-09-01
EA201692556A1 (ru) 2017-04-28
HRP20191746T1 (hr) 2019-12-27
EP3154516A1 (en) 2017-04-19
NZ727388A (en) 2021-07-30
MX374540B (es) 2025-03-06
TN2016000561A1 (en) 2018-04-04
JP2017523955A (ja) 2017-08-24
CL2016003219A1 (es) 2017-06-30
SG11201609374YA (en) 2017-01-27
WO2015193246A1 (en) 2015-12-23
JO3500B1 (ar) 2020-07-05
MX2016016635A (es) 2017-06-06
KR102360656B1 (ko) 2022-02-09
KR20150144209A (ko) 2015-12-24
ZA201608020B (en) 2020-05-27
PH12016502527A1 (en) 2017-04-10
CO2017000354A2 (es) 2017-03-31
AU2015276247C1 (en) 2020-02-06
SG10201811139UA (en) 2019-01-30
PT3154516T (pt) 2019-12-05

Similar Documents

Publication Publication Date Title
CN100374112C (zh) 罗替戈汀鼻内组合物
AU2018369241B2 (en) Pharmaceutical preparation having excellent photostability and drug release properties
TW201330873A (zh) 口服溶液
JP6615130B2 (ja) 安定化デスモプレシン
AU2023201826A1 (en) Solid formulation having excellent stability
EP2692340B1 (en) Stable pharmaceutical system (kit) for the preparation of oral solution of levothyroxine or pharmaceutically acceptable salt thereof
JP6585193B2 (ja) ゲフィチニブ含有錠剤
TW201440783A (zh) 含有米卡芬淨或其鹽的醫藥組成物
US10213437B2 (en) Pharmaceutical preparation for masked taste oral administration, containing clomipramine
WO2015073967A1 (en) Novel metabolites of vanoxerine compounds for the treatment of dopaminergic diseases
HK1235295B (en) Stabilized desmopressin
HK1235295A1 (en) Stabilized desmopressin
JP7368548B2 (ja) 薬学的組成物及びその使用
BR112016029417B1 (pt) Composição farmacêutica na forma de uma película de desintegração oral, seu método de preparação, e uso de gomas para aumentar sua estabilidade
CN104892524A (zh) 芬苯达唑微晶体的制备方法
TW201311266A (zh) 與埃紮斯特之賦形劑相容性
HK1235704B (zh) 他达拉非口腔分散膜及其制备方法

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20180607

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20180607

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20190131

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20190212

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20190509

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20191008

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20191105

R150 Certificate of patent or registration of utility model

Ref document number: 6615130

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250